Symposium – Dx Toxicology: Strategies for Success in Discovery and Development Attrition due to safety/toxicity remains a challenge in drug discovery and development. Strategies to improve success focus on asking the right questions at the right time around Target, Chemistry and Patient with an emphasis on translation of data [...]
ApconiX Welcomes Dr Steffen Ernst ApconiX is delighted to welcome Dr Steffen Ernst to our team, as the company begins its international expansion with the formation of its Swedish subsidiary, ApconiX AB. Steffen has worked in preclinical and clinical safety for over 20 years with Hoechst-Schering, Boehringer-Ingelheim, AstraZeneca, Pfizer [...]
ApconiX Welcomes Steve Snyder ApconiX is delighted to welcome Steve Snyder to the team. Steve joins the nonclinical study monitoring team and is based in Florida in the United States. Having worked at Wyeth, Eli Lilly, McNeil Pharmaceutical and Charles River, Steve has a wealth of experience in preclinical [...]
ApconiX Welcomes Dr Bjorn Dahl ApconiX is delighted to welcome Dr Björn Dahl to the team, who joins our new Swedish office at AstraZeneca’s BioVentureHub in Gothenburg. Björn is a highly respected and experienced toxicologist, having been the co-chair of the European Federation Pharmaceutical Industry Association (EFPIA) Preclinical Development [...]
ApconiX are delighted to learn that the BTS Executive Committee has elected Professor Ruth Roberts as Honorary Fellow of the British Toxicology Society (hon FBTS) in recognition of her outstanding contribution to the science and profession of Toxicology, including to the BTS. Ruth commented “It’s such an honour to be recognised in this way by [...]
Professor Ruth Roberts on SOT Ballot ApconiX is happy to announce that Professor Ruth Roberts is on the SOT ballot for the position of Vice President-Elect. As Secretary to SOT, Ruth was the first non-US based Council member and now hopes to be the first non-US based President! ‘It’s [...]
Alderley Park Companies Receive Bionow Awards Drs Michael Morton and Richard Knight thoroughly enjoyed the Bionow 2018 Awards Dinner at the Mere Golf Resort & Spa, Cheshire on 29th November. The awards which recognise excellence, outstanding achievement and enterprise in a sector that is worth more than £13bn to [...]
Highlight Article for Experimental Biology and Medicine “Drug discovery and development: Biomarkers of neurotoxicity and neurodegeneration”, co-authored by Abigail L Walker, Syed Z Imam and Ruth A Roberts, has been selected as a highlight article for Experimental Biology and Medicine’s 243:13 issue. As a result of this designation it [...]
Dr Michael Morton, Professor Ruth Roberts, Dr Richard Knight and Dr Paul Duffy will be attending EUROTOX this September in Brussels. The theme for 2018 is “Toxicology Out of the Box” and reflects the federation’s willingness and enthusiasm to offer an innovative, forward-looking and imaginative scientific programme. ‘"The theme for EUROTOX aligns perfectly with our [...]
Changes in the metabolome and microRNA levels in biological fluids might represent biomarkers of neurotoxicity: A trimethyltin study. Abstract: Neurotoxicity has been linked with exposure to a number of common drugs and chemicals, yet efficient, accurate, and minimally invasive methods to detect it are lacking. Fluid-based biomarkers such as [...]
